Skip to main content
SpringerLink
Log in

Transitional Cell Carcinoma of the Renal Pelvis: Management

  • Chapter
Clinical Management of Renal Tumors

  • 750 Accesses

Abstract

Upper urinary tract transitional cell carcinoma (UUTTCC) accounts for approximately 5% of all urothelial tumors. Surgical therapy remains the standard of care for patients with localized disease based on tumor stage and grade. Surgical options for treatment range from minimally invasive procedures, such as ureteroscopy, and laparoscopic nephroureterectomy to open radical nephroureterectomy. Surveillance with cystoscopy and cytology following surgical management is essential as currently there are no variables that consistently predict which patients are destined to develop intravesical and/or contralateral upper tract recurrences. Extrapolating from traditional bladder TCC, both regional lymphadenectomy as well as neoadjuvant and adjuvant chemotherapy are likely to be beneficial for this cohort of patients. Management of patients with advanced UUTTCC should follow current guidelines utilized for patients with bladder TCC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Munoz J, Ellison L. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000;164:1523–1525.

    Article  PubMed  CAS  Google Scholar 

  2. Melamed M, Reuter V. Pathology and staging of urothelial tumors of the kidney and ureter. Urol Clin North Am 1993;20:333–347.

    PubMed  CAS  Google Scholar 

  3. Guinan P, Vogelzang N, Randazzo R, et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975–1985. Cancer Incidence and End Results Committee. Urology 1992;40:393–399.

    Article  PubMed  CAS  Google Scholar 

  4. Hall M, Womack S, Sagalowsky A, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594–601.

    Article  PubMed  CAS  Google Scholar 

  5. Hurle R, Losa A, Manzetti A, et al. Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients. 1999;53:1144–1148.

    CAS  Google Scholar 

  6. Gilligan T, Dreicer R. The atypical urothelial cancer patient: management of bladder cancers of nontransitional cell histology and cancers of the ureters and renal pelvis. Semin Oncol 2007;34(2):145–153.

    Article  PubMed  Google Scholar 

  7. Blacher E, Johnson D, Abdul-Karim F, et al. Squamous cell carcinoma of renal pelvis. Urology 1985;25:124–126.

    Article  PubMed  CAS  Google Scholar 

  8. Takehara K, Nomata K, Eguchi J, et al. Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder. Int J Urol 2004;11:1016–1018.

    Article  PubMed  Google Scholar 

  9. Hammond E, henson D. Cancer Committee College of American Pathologists; Task Force on the Examination of Specimens Removed from Patients with Bladder Cancer. Practice protocol for the examination of specimens removed from patients with carcinoma of the urinary bladder, ureter, renal pelvis, and urethra. Arch Pathol Lab Med 1996;120:1103–1110.

    PubMed  CAS  Google Scholar 

  10. Kitamura M, Miyanaga T, Hamada M, et al. Small cell carcinoma of the kidney: case report. Int J Urol 1997;4:422–424.

    Article  PubMed  CAS  Google Scholar 

  11. Majhail N, Elson P, Bukowski R. Therapy and outcome of small cell carcinoma of the kidney: report of two cases and a systematic review of the literature. Cancer 2003;97:1436–1441.

    Article  PubMed  Google Scholar 

  12. Geersen J. Tumors of the renal pelvis and ureter. Symptomatology, diagnosis, treatment and prognosis. Scand J Urol Nephrol 1979;13:287–290.

    Article  Google Scholar 

  13. Takebayashi S, Hosaka M, Takase K, et al. Computerized tomography nephroscopic images of renal pelvic carcinoma. J Urol 1999;162:315–318.

    Article  PubMed  CAS  Google Scholar 

  14. Miller O, Rineer S, Reichard S, et al. Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. Urology 1998;52:982–987.

    Article  PubMed  CAS  Google Scholar 

  15. McCoy J, Honda H, Reznicek M, et al. Computerized tomography for detection and staging of localized and pathologically defined upper tract urothelial tumors. J Urol 1991;146:1500–1503.

    PubMed  CAS  Google Scholar 

  16. Planz B, George R, Adam G, et al. Computed tomography for detection and staging of transitional cell carcinoma of the upper urinary tract. Eur Urol 1995;27:146–150.

    PubMed  CAS  Google Scholar 

  17. Yun E, Meng M, Carroll P. Evaluation of the patient with hematuria. Med Clin North Am 2004;88:329–343.

    Article  PubMed  Google Scholar 

  18. Assimos D, Hall M, Martin J. Ureteroscopic management of patients with upper tract transitional cell carcinoma. Urol Clin North Am 2000;27:751–760.

    Article  PubMed  CAS  Google Scholar 

  19. Dodd L, Johnston W, Robertson C, et al. Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis. Acta Cytol 1997;41:377–384.

    PubMed  CAS  Google Scholar 

  20. Keeley F, Bibbo M, Bagley D. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 1997;157:1560–1565.

    Article  PubMed  Google Scholar 

  21. AJCC Cancer Staging Handbook, 6th ed. New York: Springer-Verlag, 2002.

    Google Scholar 

  22. Maatman TJ, Gupta MK, Montie JE. Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate. J Urol 1985;133:620–621.

    PubMed  CAS  Google Scholar 

  23. Terrel R, Cheville J, See W, et al. Histopathological features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of the renal pelvis. J Urol 1995;154:1342–1347.

    Article  Google Scholar 

  24. Morioka M, Jo Y, Furukawa Y, et al. Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 2001;8:30–37.

    Article  Google Scholar 

  25. Laguna M, de la Rosette J. The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor. J Urol 2001;166:2017–2022.

    Article  PubMed  CAS  Google Scholar 

  26. Koga F, Nagamatsu H, Ishimaru H, et al. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of theupper urinary tract. Urol Int 2001;67:135–141.

    Article  PubMed  CAS  Google Scholar 

  27. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003;47:155–169.

    Article  PubMed  Google Scholar 

  28. Murphy D, Zincke H, Furlow W. Primary grade I transitional cell carcinoma of the renal pelvis and ureter. J Urol 1980;123:629–631.

    PubMed  CAS  Google Scholar 

  29. Murphy D, Zincke H, Furlow W. Management of high grade transitional cell cancer of the upper urinary tract. J Urol 1981;125:25–29.

    PubMed  CAS  Google Scholar 

  30. Tawfiek E, Bagley D. Upper tract transitional cell carcinoma. Urology 1997;50:321–329.

    Article  PubMed  CAS  Google Scholar 

  31. Clayman R, Kavoussi L, Figenshau R, et al. Laparoscopic nephroureterectomy: initial clinical case report. J Laparoendosc Surg 1991;1:343–349.

    PubMed  CAS  Google Scholar 

  32. Shalhav A, Portis A, McDougall E, et al. Laparoscopic nephroureterectomy. A new standard for the surgical management of upper tract transitional cell cancer. Urol Clin North Am 2000;27:761–763.

    Article  PubMed  CAS  Google Scholar 

  33. Savage S, Gill I. Laparoscopic radical nephroureterectomy. J Endourol 2000;14:859–864.

    Article  PubMed  CAS  Google Scholar 

  34. McNeill S, Chrisofos M, Tolley D. The long term outcome after laparoscopic nephroureterectomy: a comparison with open nephroureterectomy. BJU Int 2000;86:619–623.

    Article  PubMed  CAS  Google Scholar 

  35. Gill I, Sung G, Hobart M, et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience. J Urol 2000;164:1513–1522.

    Article  PubMed  CAS  Google Scholar 

  36. Shalhav A, Dunn M, Portis A, et al. Laparoscopic nephroureterectomy for upper tract transitional cell cancer: the Washington University experience. J Urol 2000;163:1100–1104.

    Article  PubMed  CAS  Google Scholar 

  37. Cozad S, Smalley S, Austenfeld M, et al. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology 1995;46:796–800.

    Article  PubMed  CAS  Google Scholar 

  38. Ozsahin M, Zouhair A, Villa S, et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 1999;35:738–743.

    Article  PubMed  CAS  Google Scholar 

  39. Maulard-Durdux C, Dufour B, Hennequin C, et al. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol 1996;155:115–117.

    Article  PubMed  CAS  Google Scholar 

  40. Hall M, Womack J, Roehrborn C, et al. Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol 1998;160:703–706.

    Article  PubMed  CAS  Google Scholar 

  41. International Collaboration of Trialists on Behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-Urinary Group, Australian Bladder Cancer Study Group, et al. Neoadjuvant cisplatin, methotrextate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 1999;354:533–540.

    Article  Google Scholar 

  42. Grossman H, Natale R, Tangen C, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003;349:859–866.

    Article  PubMed  CAS  Google Scholar 

  43. Skinner D, Daniels J, Russell C, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991;145:459–464.

    PubMed  CAS  Google Scholar 

  44. Stockle M, Meyenburg W, Wellek S, et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 1992;148(2 pt 1):302–306.

    PubMed  CAS  Google Scholar 

  45. Freiha F, Reese J, Torti F. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle-invasive bladder cancer. J Urol 1996;155:495–500.

    Article  PubMed  CAS  Google Scholar 

  46. Bamias A, Deliveliotis C, Fountzilas G, et al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 2004;22:2150–2154.

    Article  PubMed  CAS  Google Scholar 

  47. Bajorin D, Dodd P, Mazumdar M, et al. Long-term survival in metastatic transitional cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 1999;17:3173–3181.

    PubMed  CAS  Google Scholar 

  48. Sternberg C, Yagoda A, Scher H, et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985;133:403–404.

    PubMed  CAS  Google Scholar 

  49. Loehrer P, Einhorn L, Elson P, et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 1992;10:1066–1073.

    PubMed  Google Scholar 

  50. Saxman S, Propert K, Einhorn L, et al. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative Group Study. J Clin Oncol 1997;15:2564–2569.

    PubMed  CAS  Google Scholar 

  51. Sternberg C, Yagoda A, Scher H, et al. M-VAC for advanced transitional cell carcinoma of the urothelium: Efficacy, and patterns of response and relapse. Cancer 1989;64:2448.

    Article  PubMed  CAS  Google Scholar 

  52. von der Maase H, Hansen S, Roberts J, et al. Gemcitabine and cisplatin versus methotrextate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000;18:3068–3077.

    PubMed  Google Scholar 

  53. Vaughn D, Manola J, Dreicer R, et al. Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): a trial of the Eastern Cooperative Oncology Group. Cancer 2002;95:1022–1027.

    Article  PubMed  CAS  Google Scholar 

  54. Dreicer R, Manola J, Roth B, et al. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium. Cancer 2004;100:1639–1645.

    Article  PubMed  CAS  Google Scholar 

  55. Corrado F, Ferri C, Mannini D, et al. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol 1991;145:1159–1163.

    PubMed  CAS  Google Scholar 

  56. Rey A, Lara P, Redondo E, et al. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. 1997;79:2178–2185.

    CAS  Google Scholar 

  57. Jinza S, Iki M, Noguchi S, et al. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter. J Urol 1996;155:1877–1881.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology and the Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH

    Jorge A. Garcia MD & Robert Dreicer MD

Authors
  1. Jorge A. Garcia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Dreicer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH

    Ronald M. Bukowski MD

  2. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH

    Andrew C. Novick MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Garcia, J.A., Dreicer, R. (2008). Transitional Cell Carcinoma of the Renal Pelvis: Management . In: Bukowski, R.M., Novick, A.C. (eds) Clinical Management of Renal Tumors. Humana Press. https://doi.org/10.1007/978-1-60327-149-3_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-149-3_36

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-251-3

  • Online ISBN: 978-1-60327-149-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation